Sr. Director, US Team Lead, BRAFTOVI/MEKTOVI

Job description

ROLE SUMMARY: At Pfizer Oncology, our purpose is to Outdo Cancer by delivering transformative medicines that have the potential to meaningfully change outcomes for patients. Pfizer Oncology’s industry‑leading pipeline spans breast, genitourinary (GU), hematology, gastroenterology, and thoracic therapeutic areas, reflecting both scientific depth and sustained investment in areas of high unmet need. BRAFTOVI/MEKTOVI is positioned for significant growth with the recent approval of Pfizer's BRAFTOVI (encorafenib) in combination with cetuximab and fluorouracil-based chemotherapy for the first-line treatment of adult patients with metastatic colorectal cancer (mCRC) harboring a BRAF V600E mutation. The Sr. Director, Team Lead for BRAFTOVI/MEKTOVI will lead a group of colleagues that support the BRAFTOVI/MEKTOVI colorectal and melanoma business and all pan-tumor activities. BRAFTOVI® and MEKTOVI® are key growth brands within Pfizer Oncology, delivering differentiated value across multiple BRAF V600–mutant indications, including melanoma and colorectal cancer. The therapy competes in dynamic, high‑opportunity markets that demand strong commercial leadership, disciplined execution, and data...